These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 26657276
21. In-vitro controlled release of doxorubicin from silica xerogels. Prokopowicz M. J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811 [Abstract] [Full Text] [Related]
22. Sol-gel-processed sintered silica xerogel as a carrier in controlled drug delivery. Kortesuo P, Ahola M, Karlsson S, Kangasniemi I, Kiesvaara J, Yli-Urpo A. J Biomed Mater Res; 1999 Feb; 44(2):162-7. PubMed ID: 10397917 [Abstract] [Full Text] [Related]
24. pH-sensitive supramolecular polypeptide-based micelles and reverse micelles mediated by hydrogen-bonding interactions or host-guest chemistry: characterization and in vitro controlled drug release. Chen Y, Dong CM. J Phys Chem B; 2010 Jun 10; 114(22):7461-8. PubMed ID: 20469900 [Abstract] [Full Text] [Related]
26. Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens. Seleem MN, Munusamy P, Ranjan A, Alqublan H, Pickrell G, Sriranganathan N. Antimicrob Agents Chemother; 2009 Oct 10; 53(10):4270-4. PubMed ID: 19667284 [Abstract] [Full Text] [Related]
27. Chlorophyll a Covalently Bonded to Organo-Modified Translucent Silica Xerogels: Optimizing Fluorescence and Maximum Loading. García-Sánchez MA, Serratos IN, Sosa R, Tapia-Esquivel T, González-García F, Rojas-González F, Tello-Solís SR, Palacios-Enriquez AY, Esparza Schulz JM, Arrieta A. Molecules; 2016 Jul 22; 21(7):. PubMed ID: 27455223 [Abstract] [Full Text] [Related]
28. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Zhu W, Wan L, Zhang C, Gao Y, Zheng X, Jiang T, Wang S. Mater Sci Eng C Mater Biol Appl; 2014 Jan 01; 34():78-85. PubMed ID: 24268236 [Abstract] [Full Text] [Related]
29. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S. J Control Release; 2010 Aug 03; 145(3):257-63. PubMed ID: 20450945 [Abstract] [Full Text] [Related]
31. Lysozyme as a pH-responsive valve for the controlled release of guest molecules from mesoporous silica. Xue M, Findenegg GH. Langmuir; 2012 Dec 18; 28(50):17578-84. PubMed ID: 23173551 [Abstract] [Full Text] [Related]
38. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C. Int J Pharm; 2013 Sep 15; 454(1):135-42. PubMed ID: 23871738 [Abstract] [Full Text] [Related]
39. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds. Morpurgo M, Teoli D, Pignatto M, Attrezzi M, Spadaro F, Realdon N. Acta Biomater; 2010 Jun 15; 6(6):2246-53. PubMed ID: 20035908 [Abstract] [Full Text] [Related]
40. Potential of amorphous microporous silica for ibuprofen controlled release. Aerts CA, Verraedt E, Depla A, Follens L, Froyen L, Van Humbeeck J, Augustijns P, Van den Mooter G, Mellaerts R, Martens JA. Int J Pharm; 2010 Sep 15; 397(1-2):84-91. PubMed ID: 20619331 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]